Emkay Global Financial's research report on ACC
ACC’s Q4FY24 EBITDA grew 79% YoY (down 8% QoQ) to Rs8.4bn, which was ~4% higher than our estimate. On a sequential basis, EBITDA/t declined by Rs215 to Rs802 (Emkay: Rs820), mainly on account of weak blended realizations that fell by Rs341/t in Q4FY24. Total cost/t declined 14% YoY (3% QoQ) to Rs4,379 (Emkay: Rs4,505) owing to cost savings across line items. Volume growth surprised positively with 23% YoY growth to 10.4mt, mainly led by increased MSA transaction with Ambuja/Sanghi Cement. Factoring-in the Q4FY24 performance and higher costs, we tweak our EBITDA by 2-5%.
Outlook
Given the healthy balance sheet and attractive valuations, we maintain BUY on ACC and our Mar-25E TP of Rs2,900/share (after the quarterly roll-over), based on 13x EV/EBITDA.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
